(Q32067243)

English

The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 July 2017

The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects (English)

1 reference

Europe PubMed Central

6 July 2017

author name string

D Gustafsson

1

1 reference

Europe PubMed Central

6 July 2017

J Nyström

2

1 reference

Europe PubMed Central

6 July 2017

S Carlsson

3

1 reference

Europe PubMed Central

6 July 2017

U Bredberg

4

1 reference

Europe PubMed Central

6 July 2017

U Eriksson

5

1 reference

Europe PubMed Central

6 July 2017

E Gyzander

6

1 reference

Europe PubMed Central

6 July 2017

M Elg

7

1 reference

Europe PubMed Central

6 July 2017

T Antonsson

8

1 reference

Europe PubMed Central

6 July 2017

K Hoffmann

9

1 reference

Europe PubMed Central

6 July 2017

A Ungell

10

1 reference

Europe PubMed Central

6 July 2017

H Sörensen

11

1 reference

Europe PubMed Central

6 July 2017

S Någård

12

1 reference

Europe PubMed Central

6 July 2017

A Abrahamsson

13

1 reference

Europe PubMed Central

6 July 2017

R Bylund

14

1 reference

Europe PubMed Central

6 July 2017

publication date

1 February 2001

1 reference

Europe PubMed Central

6 July 2017

Thrombosis Research

1 reference

Europe PubMed Central

6 July 2017

101

1 reference

Europe PubMed Central

6 July 2017

171-181

1 reference

Europe PubMed Central

6 July 2017

3

1 reference

Europe PubMed Central

6 July 2017

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic inhibitors of thrombin and factor Xa: from bench to bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Small, noncovalent serine protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Benzylamine-based selective and orally bioavailable inhibitors of thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The discovery of orally available thrombin inhibitors: studies towards the optimisation of CGH1668

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of the intestinal absorption of a peptidomimetic, boronic acid thrombin inhibitor possibly utilizing the oligopeptide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0049-3848(00)00399-6

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32067243&oldid=1639466992"